{"id":133272,"date":"2022-08-16T07:42:21","date_gmt":"2022-08-16T11:42:21","guid":{"rendered":"https:\/\/44.250.171.167\/?p=133272"},"modified":"2022-10-06T04:46:44","modified_gmt":"2022-10-06T08:46:44","slug":"apollo-hospitals-enterprise-limited-q1-fy23-earnings-conference-call-insights","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/apollo-hospitals-enterprise-limited-q1-fy23-earnings-conference-call-insights\/","title":{"rendered":"Apollo Hospitals Enterprise Limited Q1 FY23 Earnings Conference Call Insights"},"content":{"rendered":"<p><iframe loading=\"lazy\" title=\"Apollo Hospitals Enterprise Limited Q1 FY23 Earnings Concall\" width=\"500\" height=\"375\" src=\"https:\/\/www.youtube.com\/embed\/niPJDB-NX_Y?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<p><strong>Key highlights from Apollo Hospitals Enterprise Limited (<a href=\"https:\/\/44.250.171.167\/symbol\/APOLLOHOSP\/\">APOLLOHOSP<\/a>) Q1 FY23 Earnings Concall<\/strong><\/p>\n<p><strong>Q&amp;A Highlights:<\/strong><\/p>\n<ul>\n<li>Nitin Gosar from Invesco asked about the increase in operating cost in 24\/7. Sanjiv Gupta CFO Apollo 24\/7 replied that it was due to holding of some expenditure from Q3 to Q1 and Q2. But beyond that, the company doesn\u2019t expect expenditure to go up sequentially.<\/li>\n<\/ul>\n<ul>\n<li>Sameer Baisiwala from Morgan Stanley asked about ALOS, what\u2019s driving it down, excluding the COVID quarters and the outlook of it. Suneeta Reddy MD answered that the company is focused on driving down the ALOS, by using robotics and minimally invasive, which enables to discharge patients much faster.<\/li>\n<\/ul>\n<ul>\n<li>Sameer Baisiwala from Morgan Stanley asked about the Gurgaon project, how much capex is required for the project. Suneeta Reddy MD replied that the company has paid INR450 crores for 5.67 acres. Also there is a building existing for which maximum another INR350 crores will be invested, taking the project cost to INR 900 crore maximum.<\/li>\n<\/ul>\n<ul>\n<li>Damayanti Kerai from HSBC enquired about Apollo 24\/7 spend, where it is happening the most. Sanjiv Gupta CFO Apollo 24\/7 clarified that 25% is the expenditure that is getting into the product and the technology side of it, 30-35% is getting into the augmenting of resources and 20-25% into branding, 10-15% into user acquisition and remaining 8-10% towards other infrastructure, mainly support.<\/li>\n<\/ul>\n<ul>\n<li>Damayanti Kerai from HSBC asked about strong ARPOB numbers, and if it includes a component of price hike and if this growth is sustainable. Sanjiv Gupta CFO Apollo 24\/7 answered that on ARPOB, there was a price hike of 2% and the growth is inclusive of that. And also the company said there are good levers helping to get the ARPOB and it is sustainable.<\/li>\n<\/ul>\n<ul>\n<li>Sumit Gupta of Motilal Oswal asked about the routine and project capex plans for the hospital segment. Sanjiv Gupta CFO Apollo 24\/7 said that routine capex is approx. INR300 crores. After that the free cash flow will be INR800 crore, which is what will be used for deployment in new projects etc.<\/li>\n<\/ul>\n<ul>\n<li>Shaleen Kumar from UBS asked about the contribution from COVID vaccine at EBITDA level in a base quarter. \u00a0Sanjiv Gupta CFO Apollo 24\/7 replied there was only INR11 crores of revenue in 1Q23 and EBITDA somewhere around 12-13%. And in 1Q22, it was INR211 crores revenue and EBITDA 15%.<\/li>\n<\/ul>\n<ul>\n<li>Shaleen Kumar from UBS enquired when APOLLOHOSP will be able to close the external fund raise that was pushed by six months. Suneeta Reddy MD replied that the external fund raise should be closed by December 2022.<\/li>\n<\/ul>\n<ul>\n<li>Prakash Agarwal with Axis Capital asked about future margins, given new hospitals are getting added. C. Chandrasekhar CEO said that the occupancy is at 60% now and is expecting to increase it to 70% over the next 12-15 months. This would increase volumes by 15% and consequently revenue by 25% and EBITDA by 35%.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Key highlights from Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q1 FY23 Earnings Concall Q&amp;A Highlights: Nitin Gosar from Invesco asked about the increase in operating cost in 24\/7. Sanjiv Gupta CFO Apollo 24\/7 replied that it was due to holding of some expenditure from Q3 to Q1 and Q2. But beyond that, the company doesn\u2019t expect [&hellip;]<\/p>\n","protected":false},"author":1767,"featured_media":125416,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"Apollo Hospitals Enterprise Limited Q1 FY23 Earnings Conference Call Insights #APOLLOHOSP #Q1 #FY23  #Earnings","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[9825,392,5747],"tags":[8160,9869],"class_list":["post-133272","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-earnings-call-highlights","category-earnings","category-healthcare-stocks","tag-healthcare-services","tag-hospitals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":130633,"url":"https:\/\/alphastreet.com\/india\/apollo-hospitals-q4-fy22-earnings-conference-call-insights\/","url_meta":{"origin":133272,"position":0},"title":"Apollo Hospitals Q4 FY22 Earnings Conference Call Insights","author":"Praveen","date":"June 14, 2022","format":false,"excerpt":"https:\/\/youtu.be\/o39b8VAmN3k Key highlights from Apollo Hospitals (APOLLOHOSP) Q4 FY22 Earnings Concall Q&A Highlights: Anubhav Aggarwal from Credit Suisse asked what impacted the pharmacy segment margin that was only 6.1% in 4Q22. Obul Reddy CFO said that there was an increase in the customer discount from 10.5% overall last year to\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":133434,"url":"https:\/\/alphastreet.com\/india\/zydus-lifesciences-ltd-q1-fy23-earnings-conference-call-insights\/","url_meta":{"origin":133272,"position":1},"title":"Zydus Lifesciences Ltd Q1 FY23 Earnings Conference Call Insights","author":"Praveen","date":"August 24, 2022","format":false,"excerpt":"https:\/\/youtu.be\/R4mbpNYrIhE Key highlights from Zydus Lifesciences Ltd (ZYDUSLIFE) Q1 FY23 Earnings Concall Q&A Highlights: Neha enquired about the drivers of strong growth in the US business QonQ and if it\u2019s sustainable. Sharvil Patel MD replied that there are no one-offs in the overall numbers. The sequential growth was due to\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":128103,"url":"https:\/\/alphastreet.com\/india\/mindspace-business-parks-reit-q3-fy22-earnings-conference-call-insights\/","url_meta":{"origin":133272,"position":2},"title":"Mindspace Business Parks REIT Q3 FY22 Earnings Conference Call Insights","author":"Praveen","date":"March 3, 2022","format":false,"excerpt":"https:\/\/www.youtube.com\/watch?v=rfe3IPR8cC4 Key highlights from Mindspace Business Parks REIT (MINDSPACE) Q3 FY22 Earnings Concall Q&A Highlights: Adhidev Chattopadhyay from ICICI asked about the early re-leasing of almost 0.5 million square feet, if it\u2019s initiated by the tenants. Vinod Rohira, CEO said that it\u2019s a 10-plus years old client and wanted to\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":130453,"url":"https:\/\/alphastreet.com\/india\/glenmark-pharmaceuticals-limited-q4-fy22-earnings-conference-call-insights\/","url_meta":{"origin":133272,"position":3},"title":"Glenmark Pharmaceuticals Limited Q4 FY22 Earnings Conference Call Insights","author":"Praveen","date":"June 2, 2022","format":false,"excerpt":"https:\/\/youtu.be\/uTUQ9VpSoiU Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q4 FY22 Earnings Concall Management Update: GLENMARK said the India business continues to significantly outperform industry growth rates, continuing the trend of the past several years. The company said it filed a total of 19 ANDA applications with the U.S. FDA in\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":135808,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q2-fy23-earnings-conference-call-insights\/","url_meta":{"origin":133272,"position":4},"title":"Divi&#8217;s Laboratories Ltd Q2 FY23 Earnings Conference Call Insights","author":"Praveen","date":"November 8, 2022","format":false,"excerpt":"https:\/\/youtu.be\/e1-tljnhSVM Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q2 FY23 Earnings Concall Management Update: [00:06:48] DIVISLAB stated that though global logistics scenario has improved and is seeing receding sea and air-freight costs in 2Q23, minor disruptions stemming from issues like manpower shortages continues. [00:07:12] DIVISLAB also said that prices of\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":140051,"url":"https:\/\/alphastreet.com\/india\/dr-lal-pathlabs-ltd-q3-fy23-earnings-conference-call-insights\/","url_meta":{"origin":133272,"position":5},"title":"Dr Lal PathLabs Ltd Q3 FY23 Earnings Conference Call Insights","author":"Praveen","date":"February 3, 2023","format":false,"excerpt":"Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q3 FY23 Earnings Concall Q&A Highlights: [00:12:28] Dheeresh Pathak from WhiteOak asked about the revenue and EBITDA for Suburban for 3Q23. C. A. Ved Prakash CFO said Suburban had revenue of INR37 crores, with INR35 crores from non-COVID and the rest from\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/133272","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1767"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=133272"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/133272\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/125416"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=133272"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=133272"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=133272"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}